Noncoding RNAs Regulating p53 and c-Myc Signaling

Yide Mei1, Mian Wu2

  • 1CAS Key Laboratory of Innate Immunity and Chronic Disease, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, 230027, China.

Insights

This chapter reviews noncoding RNAs, including microRNAs and long noncoding RNAs, that regulate tumor suppressors like p53 and proto-oncogenes like c-Myc. Understanding these interactions is crucial for cancer research and clinical applications.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • p53 is a critical tumor suppressor, while c-Myc is a proto-oncogene frequently activated in human cancers.
  • Both p53 and c-Myc are central regulators of cellular processes and decision-making.
  • Dysregulation of p53 and c-Myc pathways is implicated in tumorigenesis.

Purpose of the Study:

  • To comprehensively review the role of noncoding RNAs in regulating p53 and c-Myc.
  • To highlight recent advancements in understanding noncoding RNA involvement in p53 and c-Myc networks.
  • To discuss the implications of these regulatory mechanisms in basic science and clinical settings.

Main Methods:

  • Literature review of recently published studies on noncoding RNAs.
  • Analysis of microRNAs and long noncoding RNAs acting as regulators and effectors for p53 and c-Myc.
  • Examination of intracellular and extracellular pathways involved in these regulations.

Main Results:

  • Noncoding RNAs, including microRNAs and long noncoding RNAs, are significant regulators of p53 and c-Myc.
  • These noncoding RNAs modulate the complex network of cis-elements and transfactors affecting p53 and c-Myc.
  • Recent research demonstrates diverse mechanisms by which noncoding RNAs influence p53 and c-Myc activity.

Conclusions:

  • Noncoding RNAs play a pivotal role in the intricate regulatory network of p53 and c-Myc.
  • Further investigation into noncoding RNA functions offers potential for novel therapeutic strategies in cancer.
  • Understanding these interactions is key to advancing both fundamental cancer biology and clinical oncology.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K